A news brief in the Dec. 17, 2004, issue of BioWorld Today should have said Senesco Technologies Inc. will investigate its Factor 5A technology in multiple myeloma and its inhibitor of eukaryotic initiation factor 5A in sepsis in two preclinical studies at major research institutions.

Editor's Note: The correction has been made in BioWorld Online.